Strontium Therapy

Strontium Therapy is a radiopharmaceutical treatment modality that uses intravenous strontium-89, a beta-emitting radionuclide, to selectively target and irradiate metastatic bone lesions for the palliation of cancer-induced skeletal pain.

331

Publications

15K

Citations

1.4K

Authors

554

Institutions

Publications per year

2017–2026

24

Variants

89Sr Therapy

Publications

331

1–5 of 331

Authors

1.4K

  1. JR
    Jean‐Yves Reginster

    University of Liège, Belgium

    9 publications · 491 citations

    9

    h-index

  2. OB
    Olivier Bruyère

    University of Liège, Belgium

    8 publications · 386 citations

    8

    h-index

  3. CR
    Christian Roux

    Hôpital Cochin, France

    8 publications · 411 citations

    8

    h-index

  4. AM
    Alexander McEwan

    University of Alberta, Canada

    7 publications · 1.4K citations

    7

    h-index

  5. DM
    D. M. Ackery

    Southampton General Hospital, United Kingdom

    6 publications · 749 citations

    6

    h-index

1–5 of 1.4K

Venues

  1. PubMed

    Repository · 41 publications · 1.1K citations

    20

    h-index

  2. Osteoporosis International

    20 publications · 1.1K citations

    17

    h-index

  3. 10

    h-index

  4. Bone

    9 publications · 455 citations

    9

    h-index

  5. Cancer

    7 publications · 236 citations

    7

    h-index

1–5